U K
B U S I N E S S
P A R K
home page

The information below comes from the UK Activity Report.
Click here for further details

Genzyme Genzyme is planning to expand its pharmaceuticals factory in Haverhill, in order to increase production of the bulk polymer product for its kidney disease drug. 21-Feb-2008 Genzyme of the US is to set up a biotechnology research facility in Cambridge this year, with 150 staff. 14-Jan-2004 Cambridge Antibody Technology is to sell an 11% equity stake to Genzyme of the US for £23m, as part of a collaboration between the two companies in the development of drugs for fibrotic diseases. 23-Sep-2003 Genzyme has won US and European approval to start producing ingredients for a kidney drug at its new £55m plant in Haverhill. 25-Aug-2003 Genzyme of the US is to build a £37m biotechnology production plant in Haverhill to meet rising demand for its Renegal kidney drug, with the creation of 200 jobs. 02-Feb-2001 Genzyme is planning to build a £12m plant in Haverhill, Suffolk, to produce the active chemical ingredient for Renagel capsules. 26-Apr-2000 The information above comes from the UK Activity Report Copyright UK Business Park 1995-2008